ARS Pharmaceuticals | DEFA14A: Others
Apr 26 16:09 ET
ARS Pharmaceuticals | DEF 14A: Definitive information statements
Apr 26 16:08 ET
ARS Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 21 17:13 ET
ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 21 16:10 ET
ARS Pharmaceuticals | 8-K: Current report
Mar 7 13:00 ET
ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates
Nov 9, 2023 16:02 ET
ARS Pharmaceuticals | 8-K: Current report
Sep 25, 2023 16:17 ET
ARS Pharmaceuticals | 8-K: Current report
Sep 20, 2023 06:05 ET
ARS Pharmaceuticals | 8-K: ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates
Aug 10, 2023 16:05 ET
ARS Pharmaceuticals | 8-K: Current report
Jun 28, 2023 16:32 ET
ARS Pharmaceuticals | 8-K: Current report
May 16, 2023 16:31 ET
ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
May 15, 2023 09:03 ET
ARS Pharmaceuticals | 8-K: Current report
May 9, 2023 09:12 ET
ARS Pharmaceuticals | DEFA14A: Others
May 1, 2023 16:35 ET
ARS Pharmaceuticals | DEF 14A: Definitive proxy statements
May 1, 2023 16:30 ET
ARS Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Apr 20, 2023 17:19 ET
ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 23, 2023 16:09 ET
ARS Pharmaceuticals | 8-K: Current report
Mar 13, 2023 09:26 ET
ARS Pharmaceuticals | 8-K: Current report
Feb 22, 2023 16:11 ET
ARS Pharmaceuticals | 8-K: Current report
Feb 14, 2023 06:12 ET
No Data
No Data